ῌ
20
ῐ῍
ῌ῎
῍365 vwx%» 2010
1)1)
῍
!1, 2)"#1, 2)
1)
1)
$%&%'
2)
$%%&%%()*
%!"
+#$ 21 % 6 , 12 &'- #$ 21 % 11 , 9 &(.
;
/- 0
)- * )+,12345678249:- -./01
<2=>?@ $%&%'
9/- /AB
C
DEF3- GH2IJ2KLM$NKO2D7PLQRSTU9- 2007 % 10 ,- L
VW 365 S@ /AB
-.34X5L-
6AX5YZ
`a789/'
2008 % 9 ,e9 1 %A;<>?S
2,516 f-.
Th- 54 f +44 =. 23.1i<-.b34>?S
k
34l0>?@mLA
[\7]9^_N
:b4cS@ 2007 % 10 ,d
/ 234 f9:- g
9:RS@ g?j-.
NSbgn- -.LQRSgb9l0>
?<^_>?S)= 10 =- l0<Bo>?S)= 6 =- l0<pC>?>?S)= 23 =
9:RS@ q5rsDE/I
>?-
;<tj;<u 5 Fe9 CRP GvH
LwQNSxJyKS#zl0{LM|}- q5rsDE
NONP 40,000 ~|9€S@ 01tQ;
+,- SƒTU- „&UV
@
X2.b
[\- ˆN
;<- W;
YL‡Z[N- \
]^‰Š
<- ‚R)Sƒ
LSNS}b†Uj?
365 9Wgb<
L>j‹c}bŒZ?@
Key words: blood culture, sepsis, bacteremia, overtime examination, antibiotics
῏
*
ῑ
;£
)/- ‚R)ŽNS7_.)`)‘’
(systemic inflammatory syndrome; SIRS) b4
>
?@ X)“abX)‚R) (severe sepsis)- *
L¤tau2<:@
/- vwx
9¥}+, Š
œ- 01.<2=>?
-.
<‹
y9:@ y¦-
bP§sRz{¨L:Z©|}9
).q”•– (septic shock) b‚R)>j;—“
agb/- ª‚&.}VcS¥~
La€- Wb˜™cd7)‘’ (multiple organ dys-
a}l0U€«9:ba<
function syndrome; MODS) Lš€gagbtj-
:3)@ 01;
0eN- fg;l0L1›t>?ag
ƒAL‚N- €«9"¬;l0ƒ„L­
b<xJhuL€œža1, 2)@ NS<R
cab†Uj?- 9/- t®¯
]/- SIRS iQjŸbˆSƒklmn
+U°„‚R
Team; ICT) tj
oJpqr
20 (¡860῎8556) $¢s 1῎1῎1
$%&%'
TEL: 096῎373῎5696
FAX: 096῎373῎5687
E-mail: [email protected]
vwx%¼½ Vol. 20
No. 1
2010.
bN
< empiric therapy
± I 2 s (Infection Control
365 L²œ2
?€S4)@ ˆg9- 2007 % 10 ,- -.34X5L6AX5YZ
>
[\7
] +³u56•Gb†´a. 9^_N- vwx
]2]|}e- µ„<Ne;¶·•–
F•¸
LnNS@ ‡ˆ/-
365 DE-
‰- &U¹º‰9¶
674 365 gº¢»¼
21
S6Yw\`a*b c$%*=>?
ƒ$%„@st ABC4 D†EF‡
ˆ+5‡‰GHXG^G
!
B ŠABC4 D†H
EZG[Y)
I. (1) 2007
'('
10 "#2008
9 "$ 1
2 34
512
/01
M
< =>?@AB 198 8
C
!
2Œ Ž(P‘ L
!
(3) 67 2,516 8
96 752 8 6 1,764 8: ;
(xyA$%‹I
JST%,4.\`a*b c
$%=K
%&
))*+,-.
’67&'NS
!
! 67
“ EF6O”•P 1 –
Q2—
˜[z™Aš›™[œ—
B D E F G H E I J 6 7 BacT /
6O”•%˜
ALERT 3D system K L%B 7 %
D†( ICT 2 žŸ
! B DEFGHEI SA ?@
! c$%
\`a*b (
! T%R*B ABC4
(‹I
DE
1
ICT
a¡S
! S.
A 9MN: SN ?@A 9ON: P2
rBEZG[ ICT ¢6OT£¤UV¥¦
Q2 1 RS!K =>B
§W
( U¨
PF ?@A 1 K
RXd0B 6Oª_
(2)
!
!
©‹I
(§" UV
¥¦§W" *+ T%67&'d0
T%,674UVWXAY EZG[
1d
«Y_
! 1
x y A
934 ": 2#3 "\A]^#_ 1) 67
pzGH‹I.B \`a*bxyApzGH¬
$% 2) &'?@A(Y) 3) \`a*b 4)
ZT%*+
c$% 5) +,- 6)
!
./ 7) d01d
e@f]Vg\ 91 T% 30 #23h2 i: jk
l4.B5m@f]Vg\nC
! $
%,674[o]pq]@Y
! T%,
! c$%BxyApzGH{v \`a
P 1.
!
RXd0
!
67?@A 2 1 }12
^ 2 ›G@jk]_4
(5) st
!
!
67&' 44 ` µa¶ bc"
;%}
€$%<stB‚Fg@5m ICT *+U
&' #\}€5²] &'$³´
&'|} \`a&'7} \`a~'|} \`a
~'7} 89:}$% 1
(§B(§žA
(4) 4.B r 1 i67$%n &
T%‹IŠ­™g
V¥¦§WB®¯°[±
T
'st UVWXAuvS6Ywn
ª_
c$% #\} ·}def¸¹_4
’67&'NS
!
“EF6O”•
gºABC'½± Vol. 20
No. 1
2010. 21
³´µ¶·¸
22
(6) 365 N% l
365 6
"
#$
(2)
)*+s
"tu
!
"#$
%&'(
)*+,
%
234 iy ./o"nCs
1) &'(
)*+
,-./
12345
678
">?@-A
` 54 i z44 { "ST Ar`|}
5 9: ;0
CRP 0
<=
BC+ &'(D
E
F8G%
365 )*+
LMH'IJKG@-N
U2VWX
<= 365 nCOP
‡@% ˆ
+
‰Š‹Œ‹Ž @-OP
^_
)*+` Welch
ƒ„
*ef~
‘’
”•“
£‘’ ¤¥
Y
(3)
">?%
<=0
]@
t $*+#$
pa0.05 "SCbc ^_ST%
–—˜~
™w˜“
OPžŸ
¦
x‚
„
"` 345¡* ¢
xC%
365 1 -.
2 /01
234
†3
2

† 2
3) Z[\
365 ~
23.1€N% Ar‚./o"
š› œ‚
9:+ OPQRST
;0
“
2) H'IJK
-
<=h nvw`NnxC%
1!
1 ST
mno 2p *qr
‡@BM
1!
efg
2,516 iy 2 §¨©ªe` 592 i
SCš A
Wh
23.5€"
2 §¨©ªe 592 iy 2 §¨©
s«C` 45 i (7.6€) " o
2p`
Streptococcus sp. (35€), Staphylococcus aureus (S.
II. aureus) (17€), Enterobacteriaceae (16€), Pseudomo-
(1) 365 365 6
,Bd
efg Wh ,Bdih
j 1.
nas aeruginosa (P. aeruginosa) (9€) "SC% Q¬
1!
)*+ j 1
1 §¨©
k
365 6
­` 27 i (4.6€) " o
2p`
CNS(32€), Enterobacteriaceae (14€), P. aeruginosa
1!
efg
6
Wih ih
1!
efg h
1 STh
h
®¯
1,017
5.7
36 (14.0€)
2,516
6.9
75 (10.0€)
z
58 ( 7.4€)
159 ( 9.0€)
ῌCNS (23)
῍Enterobacteriaceae (18)
῎S. aureus (17)
ῌCNS (52)
῍Enterobacteriaceae (41)
῎S. aureus (34)
mno
{
°¯
2 ( N)
† 2.
22 &¹¢º»¼½ Vol. 20
No. 1
2010.
„
±²
%&'(
a 365
‰ 3.
; 2.
./
>?@
>?@hi4
Ÿ
p
¡¢
23
%&'( 2 kŠ‹ŒŽ
)
345HI
N
A4
%&'(
ž
*+./01234567
89
3458Z fg ‘8 ‚*+
’“
23 9 (VCM 6 PCs 1 VCM”PCs 1 , Cars 1 )
2
9
2
1
fgVWXNY@R
•4 – 16 1 (Cars)
1
13
1
0
fgVWXNY@R •7 –
klmnEoLUR •5 –
NSTLUR •1 –
stuv4
3
0
3
0
0
0
8Z —˜U™šR
>?@
2
0
0
1
0
1
fg >LMNOPQR
i4
›œ
•2 –
44
 PCs NSTLUR Cars VWXNY@R
`]K
(9) (4) ab\]cdBe345:fgB
F 9 !" 4 VWXNY@R5cd
Enterobacteriaceae 12
CNS 11 S. aureus 5 P.
2) >?@hi4,-./BCDE
aeruginosa 4 Candida sp. 3 >?@hi4./BF 16 (85.2) 1
(5) #2
9
54
$%&'(
!" 46
8ZJKF 1 jklmnEoLU
%&'(
)
./01G34567HIJKF 1 jVWXNY@R5cdJK 345
*+,-./01234567
R5\]VWXNY@R5p
8Z
ab
89:; 2 0<=
\]cdBe345:fgBF 13 1) >?@
qrVWXNY@R5 7 klmnEoLUR5
>?@
A4./BCDE
A4./BF 23 ./01G34567HIJKF 9 G !" 8 )
*+./
0345
H I J K > L M N O P Q R 5
(VCM)
5 3) stuv4,-./BCDE
67
stuv4./BF 3 wK,-
Vancomycin
./x0KcdBeVWXNY@R5\]
67HIF 7 N
3v45pyz58ZJK
STLUR5 2 VWXNY@R5 1 (6) 3458ZJKF 2 [
{a|}~ >?@€
" )
*+./
0NSTLUR5
!
Piperacillin
(PIPC) \] VCM 0^_03458ZJK
)
*+0e‚*+
2 ƒ„B Propionibacterium sp. 0\\‡]w >?@
jŸ
†JK
A4./Be ˆ
£„¤¥¦§ Vol. 20
No. 1
2010. 23
³´µ¶·¸
24
Enterobacter cloacae !"#$%&'()*+,-./0 123
365 5 !
A
+/CD
B49:;<
=>
?CDbcdefg 95,630E185,776 hFGH
I :;
TUVMWX
;
54,026E68,921 h QRS
H
^_`aG
// pY0.29), 365 !49:
+i 40,000 h/jg
"#
1) %456
CRP 83@ 4
56
III. $
5 !7/ CRP 8
365 !49:;<
A
=>?%456
B49:;<
5 !7/
=>?%4
5 !7/ CRP /CD8 6.03E7.72 mg/dl
FGH
/
I :;
4.77E5.29 mg/dl J
KLM (SD) /NOP QRSTUVMWX
// ( pY0.47), 365 !49:;
GH
=>?^_`aG
bcdefg3@ 5
/
CRP (7)
365 !49:;<
H
Z[\]
%
%&/klm nom
2) ^_`aG
+/CDbcdefg
tu%&'
= v!/wxyz%&{|493}~
? €%&
‚ƒ„
H
v!
wxyzŽ%6
P/%&'
Ÿ
rX‚ƒ„%&_
†‡Fˆ‰Š?‹ŒFGH
‘’ k
="#$%&'()I“
?/”•FG?5) 
pqa)rs
–—~˜™š›œž
¡ ¢yzŽ/yz %63£¤¥ž¦§
@ 4.
365 !49:;< F/%456 5 !7/ CRP 8/¨©
:;<ª nY25 :; ª nY42 «/¬­®­ JKLM (SD) 3AŠ Welch / t %.3£H
{| SD /NOP 2 ¯ƒ/CD8 °Š?UVM± FX H
¢:;<¯ª 6.03E7.72 mg/
dl :; ¯ª 4.77E5.29 mg/dl, pY0.47² :;
Z[\]3A @ 5.
365 !49:;< F/^_`aG +/bcdefg/¨©
:;<ª nY25 :; ª nY42 «/¬­®­ JKLM (SD) 3AŠ Welch / t %.3£H
{| SD /NOP 2 ¯ƒ/CD8 °Š?UVM± FX H
¢:;<¯ 95,630E185,776
h :; ¯ 54,026E68,921 h pY0.29² :;
^_`aG +i 40,000 hjg 24 !B¹º"#$So» Vol. 20
No. 1
2010.
" 365
!
"#$
°2mŠ
25
0012Mo' 2%5#,
!2
‘ ?]@
A
eF%5 7$ab
N#`?]@
A
cBeF5K
$
`?
%6)& "' "( 43 7%5& Ž$’“”pqr'75 stk
)*"#+,
”pk k•#u0
-./$ 34 0
12'"3$ 4 5& 365
2 2 4#
!"##6#758 9":
;2<$% =>#?
2'$
-./2&@AB '(2CD
E%5
#’“–vw6v
"(
{2e#y5# 4P ICT
1
a{|™š
›
2}~ JO € e#?]
@a{A 2\"\0`v
":;#JK-.$H"+
>b&
6L
)
+0 2P2ƒ—.~˜zrK G#J?]@
F)*'G52$ H"+ ,05 I)*
MN'7%5&
[†E
x'7& l!2W
‚'7
d5 5) 9"$%#ƒ<
#O%$ /0P21
2$%#Q3#RS6
N,F
05& 1
$ ghJ„2
^2]gh2] 2
,
2
„&†#O8gh
$ gh2
& 4T25'$ "#JK
]‡ˆ
2
žbgh2i] $%052 >bF5& 7)
(9.7U) $ V W 8) A X 6 9) 2 Y7
Z[8 2:;'78 9:\
10U
2:\A]^2_2$%:;;`
2:;
%5<=$
2 44
16
'9":; #?
eF5& fE#$
gh2i] 05j
P Methicillin-resistant
'$ FGk$
Staphylococcus
aureus
staphylococci (MRCNS) 2lH2>
VCM 2A
5j
%J8 gh^2]
'$ I]mJK2L%Wn]2M`o
p'Go
P
0
0
Q]
pqrs@2tNA e#O
05j
Q]@2A
,F5
"#?2‘’¡ Y
h\0 h=¢o/£h
“¤2"_5¥šgvq6
%'7&
l!2"#$ ”#•¦5
EmŠ2§
‘ kx–{;#—¨05& !"#P#a5
?˜#©6™Mš7587 40,000 ª2
›«$ wU¬=¢ œŽ¬=¢#­®.
b5& d5 ?]@#©6™2§‘ #Ž
'$ 9":; #?
ž2Ÿ
d¡K2¢_d'¯>bF‡ l
Ru'7& v2v
!2kx–°2mŠ$ 4T£0b5±h2
$ S 4 #T05O#vF2wU2 xy#z
2'7²& 365
RS50& VK2G#$W{|}
kx–°2mŠ 2
q~h2X?]@A
LYeF
! ?@‚?]@#
5
= . ƒ 6 , „ de?`O[†E#\"0
!2tN#O8 4Pe
¤0&
±h2O# l”³#O%" 365
9":;#O8€] L%eF5Z'W{
escalation G#:
(E#
-./2L%]0#JK
ghJ„2( $%2
(MRSA) A Methicillin-resistant coagulase negative
ŠI]"#‹Œ0(
)
&ŸF5#a5 Ž,F& 4Pv2O<
`6O
a%52 >bF&
]@2A cBd5$CD
U
œ655„‰ ]0]
°M%2mŠ0b5v
$¥
%
4T¦T05:;2§'$ d´12mŠ§
¨©#ªµ05
$NbF& 4P e#!
KF‡& d5 Kollef 10)$"]]2$^
"#P#JK>-2«[ ¬§
2<8A?]@2_` &ab'7%5cd 12e
‚K§ 7$·­®w¯# "¦]P 5
f
CRP j 7$wUMš7582°¸?]@|
$ 7 2.5 g#h
0& 1%
5Ci#J S 4 #T05O# CRP j2ˆ
±¹#?!"#² ³º6v
k#?
l!2
‰ 2?]@A Ru2CD# l!
vFZ_d'#mŠ'G5v
$ ,F,F#
%
T6v
b‡wU¶2
E kx–EmŠ§%
2
'GF‡
$%G8
'G0F& d5 4T´0
‹‡0Œ8'7& e#‰ ! 05
5"¦]P 5
v
582°¸?]@|±¹±h# mŠ§E#T
#O8 I
L v
Ci6
56
L
v
$ I^2'7
Žn2‰ 2c#@'m
{;DbB&
2 CRP j 7$wUMš7
0µ0\¶·0`v
‚'7& »
GNGv2O¸¼¹º#NK ½» l
•¼½ Vol. 20
No. 1
2010. 25
º»¼ˆP
26
365 IV. ῍
ῌ
&'
3)
!
" #
3<$
.56789
K*>1
T
Q1>
-R
S-
9 QUVW
6)
.Z[K>>\
.>>]^_`!a"b
cde>#fg$
kl>
5)
L ./0M
+&4
X 365 Y
4)
(=#>?@ A
.#BC DEF GHIJ6
NO6P
$
()*+ ,-,- ./0#1
234
:;
2)
῎
%
7)
%hi_&j'f
8)
m()*nY + 20 o( .,"-pq.q
r
AsUVW/0X:
9)
C t12134 u
ῐ
1)
῏
American College of Chest Physicians/Society
of Critical Care Medicine Consensus Conference. 1992. Definition for sepsis and organ failure and guidelines for the use of innovative
therapies in sepsis. Crit. Care Med. 20: 864.
26 ( .,"-p½¥ Vol. 20
No. 1
2010.
10)
56 vw 2007w xy^7zrS{|8}
9 :Uz~;w
.>€w 84: 1343῍1348.
Munson, E. L., D. J. Diekema, S. E. Beemann, et
al. 2003. Detection and treatment of bloodstream infection; laboratory reporting and
antimicrobial management. J. Clin. Microbiol.
8: 427῍430.
‚<vw 1998w UVƒ<„( =1
(1)w |^7z>UVῌ$w
.
>? 46: 887῍892.
†@ABw 2006. ‡CUVˆ{‰|
DE Š‹ŒN6Ž 3D Fw
.>,
"- 33: 72῍76.
‘’ w 2006.
“UVYG”Hr*
,- 9ῌ•09 bUV> @
9w –—˜™PˆŒ‹š›œ6 34: 449῍453.
IJῌ (K? LMNOž Pw 2004w
UVŸŽP‡CDEfDQR #S
TWf¡¢K£¤w ^7z¥ 78: 959῍966.
¦‘K§ (6¨ ©ª`]U Pw 2006w `
«p•pVW>QrSUVX
YZ>¬|[­\]w `«•¥ 54: 257῍
263.
®@¯° ^ ±]U _²³ Pw 2007w
´`#µ¶·G6a¸>QrS 5 [¹UV
bc]w ,¥ 17: 284῍289.
Kollef, M., G. Sherman, S. Ward, et al. 1999.
Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality
among critically ill patients. Chest 115: 462῍
474.
365 27
Everyday Surveillance System of Blood Culture Samples without Exception:
Clinical and Economical Contribution
Hiroko Yoshinaga,1) Masanori Ohkuma,1) Katsuyoshi Ikeda,1)
Konen Obayashi,1, 2) Yukio Ando1, 2)
1)
2)
Department of Laboratory Medicine, Kumamoto University Hospital
Department of Diagnostic Medicine, Graduate School of Medical Sciences,
Kumamoto University
Blood culture is very important to make a definitive diagnosis for bacteremia, sepsis, infective
endocarditis, meningitis, contagiousness arthritis, and serious bacterial pneumonia. Quick reporting
system on blood culture testing has a big impact on the recovery of those patients. However, in Japan, few
clinical laboratories at hospitals have the examination and reporting system every day without exception
through a year. For the strong requirement from clinical sides, in October 2007, we started to prepare the
system of processing blood cultures as overtime examination at Department of Laboratory Medicine,
Kumamoto University Hospital. After we started the system, the therapeutic performance, such as
C-reactive protein improvement, was e#ecturely improved in patients with sepsis, and the mean medical
expense of each patient was diminished in comparison with pre-introduction of the new system. Everyday
surveillance of blood culture samples is an excellent system not only to contribute the therapy but also to
reduce the medical expenses in patients with sepsis.
Vol. 20
No. 1
2010. 27